CDC Viral Hepatitis Action Coalition
Published on CDC Viral Hepatitis Action Coalition (http://www.viralhepatitisaction.org)

Home > Printer-friendly

News

  • July 25, 2012 | Clinical Infectious Diseases

    VHAC-supported Clinical Infectious Diseases articles

    The Clinical Infectious Diseases recently released a series of supplemental articles related to the impact of the hepatitis C virus.
    Read Articles >

  • July 23, 2012 | Federal Register

    CMS Proposes Part B Payment for Hepatitis B Vaccine

    The Centers for Medicare & Medicaid Services proposes to add "persons diagnosed with diabetes mellitus" to the list of high-risk beneficiaries eligible for Medicare Part B coverage for the hepatitis B vaccine. If finalized, the expanded coverage would begin on January 1, 2013.
    Read the Proposed Rule >

  • July 23, 2012 | NIH News

    NIH scientists identify likely predictors of hepatitis C severity

    Scientists at the National Institutes of Health (NIH) have discovered several key factors that may predict the viral evolution and rapidity of hepatitis C in patients infected with this virus.
    Read Article >

  • July 23, 2012 | Medscape

    Hepatitis B Vaccine for Adults With Diabetes

    The Centers for Disease Control and Prevention's (CDC) Dr. Trudy Murphy discusses the new recommendation to vaccinate adults with diabetes mellitus for hepatitis B.
    Read Article >

  • July 17, 2012 | blog.AIDS.gov

    Assistant Secretary for Health Howard Koh Shares Hepatitis B Awareness Tools for AAPI Communities

    This article highlights the recent work of U.S. Department of Health and Human Services Assistant Secretary for Health, Dr. Howard Koh, to address hepatitis B in Asian American and Pacific Islander communities.
    Read Article >

  • June 28, 2012 | New England Journal of Medicine

    Overcoming Barriers to Care for Hepatitis C

    A recent article identifies lack of diagnosis – due to lack of knowledge and awareness among providers, persons at-risk, policymakers and the public – as a key barrier to treating patients with hepatitis C.
    Read Article >

  • June 20, 2012 | Centers for Disease Control and Prevention

    Viral Hepatitis Surveillance – United States, 2010

    The CDC has released their “2010 Viral Hepatitis Surveillance Report” which summarizes national surveillance data for viral hepatitis. The data shows declining rates of acute hepatitis A and acute hepatitis B during 2006 –2009, as well as stable rates of acute hepatitis C. However, new infections of hepatitis A, hepatitis B, and hepatitis C remain common.
    Read Report >

  • June 14, 2012 | Hepatology

    Awareness of Infection, Knowledge of Hepatitis C, and Medical Follow-Up Among Individuals Testing Positive

    A recent study shows that almost half of those infected with hepatitis C may be aware of their infection status. More aggressive efforts are needed to both identify and test persons at risk of infection.
    Read the Study >

  • June 13, 2012 | AIDSMap

    Doctors in Europe and the US disagree over the pace of liver fibrosis in men co-infected with HIV and hepatitis C

    Conflicting studies have been published among European and American investigators that highlight discrepancies on the pace at which liver fibrosis spreads in men co-infected with hepatitis C and HIV.
    Read Article >

  • June 11, 2012 | Infection Control Today

    More Than 27% of LA Homeless Adults Have Hepatitis C, and Nearly Half Don't Know It

    A new study found that almost 27% of homeless adults in downtown Los Angeles are infected with hepatitis C. This is more than ten times the rate of the general U.S. population.
    Read Article >

  • < Previous
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next >

© 2013 Viral Hepatitis Action Coalition, Inc. All Rights Reserved.
Privacy Policy | Member Area

Disclaimer: The information provided on www.viralhepatitisaction.org is not medical advice and is not intended to replace or supersede any information your health care provider may have given you. All health care decisions should be made with your health care provider. No changes in your health care treatment, management or medications should be undertaken without first discussing the safety and probability outcomes of such changes with your health care provider.


Source URL: http://www.viralhepatitisaction.org/about/news